Prenetics Global Stock Quote PRE - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

5.50

Bid

5.25

Ask

5.50

Volume

239

5.35 Day's Range 5.50

2.85 52 Week Range 7.838

Market Cap

67.129M

Previous Close

5.50

Open

5.50

Last Trade

5.27

Last Trade Time

10:26:21

Financial Volume

VWAP

Average Volume (3m)

13,239

Shares Outstanding

12,205,200

Dividend Yield

PE Ratio

-1.04

Earnings Per Share (EPS)

-5.31

Revenue

22M

Net Profit

-64.78M

Prenetics Global Ltd is a diagnostic and genetic testing company. It focuses on bringing health closer to millions of people globally and decentralising healthcare by making the three pillars, namely, Prevention, Diagnostics and Personalized Care, comprehensive and accessible to anyone, anytime and ... Prenetics Global Ltd is a diagnostic and genetic testing company. It focuses on bringing health closer to millions of people globally and decentralising healthcare by making the three pillars, namely, Prevention, Diagnostics and Personalized Care, comprehensive and accessible to anyone, anytime and anywhere. It has operations across nine locations, including the United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. The company develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

www.prenetics.com

Headquarters

Camana Bay, Grand Cayman, Cym

Founded

Prenetics Global Ltd is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker PRE. The last closing price for Prenetics Global was $5.50. Over the last year, Prenetics Global shares have traded in a share price range of $ 2.85 to $ 7.838.

Prenetics Global currently has 12,205,200 shares outstanding. The market capitalization of Prenetics Global is $67.13 million. Prenetics Global has a price to earnings ratio (PE ratio) of -1.04.

Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham

The Next Big Thing in Wellness? IM8 Lands in the U.S. with a Star-Studded Launch. David Beckham and a world-class scientific team are putting the focus back on foundational health CHARLOTTE...

Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

– David Beckham Co-Founded Premium Supplements Brand Sets the Standard for Science-Backed Excellence – Tested for 280+ banned substances, trusted by global athletes in WADA, NFL, NBA, MLB, PGA and...

Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

Collaboration to Focus on Nutrition, Cellular Rejuvenation, Protein, Collagen and Overall Wellness IM8, a New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com...

Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISSCollaboration Aims to Enhance Healthspan on Earth and Improve Astronaut Health in SpaceIM8, a new premium supplements brand...

Prenetics Announces Participation in December Investor Conferences

CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the...

Prenetics Announces Third Quarter 2024 Financial Results

Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand Tencent Invests $30 million in Insighta’s Early Cancer...

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced...

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced...

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

CHARLOTTE, N.C., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, announced today that management will participate in the Sidoti Virtual Micro Cap...

Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection

HONG KONG, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.08	-1.43369175627	5.58	5.8	5.16	56180	5.5103588	CS
4	-0.15	-2.65486725664	5.65	6.02	5.16	20539	5.61206162	CS
12	0.91	19.825708061	4.59	6.02	4.07	13239	5.31072689	CS
26	-0.18	-3.16901408451	5.68	6.97	3.72	15964	5.09648138	CS
52	0.65	13.4020618557	4.85	7.838	2.85	48783	4.85400737	CS
156	-120.5	-95.6349206349	126	131.25	2.85	151550	26.37098157	CS
260	-120.5	-95.6349206349	126	131.25	2.85	151550	26.37098157	CS

PRE - Frequently Asked Questions (FAQ)

What is the current Prenetics Global share price?

The current share price of Prenetics Global is $ 5.50

How many Prenetics Global shares are in issue?

Prenetics Global has 12,205,200 shares in issue

What is the market cap of Prenetics Global?

The market capitalisation of Prenetics Global is USD 67.13M

What is the 1 year trading range for Prenetics Global share price?

Prenetics Global has traded in the range of $ 2.85 to $ 7.838 during the past year

What is the PE ratio of Prenetics Global?

The price to earnings ratio of Prenetics Global is -1.04

What is the cash to sales ratio of Prenetics Global?

The cash to sales ratio of Prenetics Global is 3.05

What is the reporting currency for Prenetics Global?

Prenetics Global reports financial results in USD

What is the latest annual turnover for Prenetics Global?

The latest annual turnover of Prenetics Global is USD 22M

What is the latest annual profit for Prenetics Global?

The latest annual profit of Prenetics Global is USD -64.78M

What is the registered address of Prenetics Global?

The registered address for Prenetics Global is 94 SOLARIS AVENUE, PO BOX 1348, CAMANA BAY, GRAND CAYMAN, KY1-1108

What is the Prenetics Global website address?

The website address for Prenetics Global is www.prenetics.com

Which industry sector does Prenetics Global operate in?

Prenetics Global operates in the LAB ANALYTICAL INSTRUMENTS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FOXXFoxx Development Holdings Inc	$ 8.9899 (211.07%)	6.51M
AMODAlpha Modus Holdings Inc	$ 3.7799 (145.45%)	71.15M
TECXTectonic Therapeutic Inc	$ 51.00 (98.29%)	3.03M
KZIAKazia Therapeutics Ltd	$ 2.095 (51.81%)	83.61M
ATHEAlterity Therapeutics Limited	$ 4.07 (39.86%)	16.12M
CLEUChina Liberal Education Holdings Ltd	$ 0.8022 (-89.65%)	53.5M
CRGXCARGO Therapeutics Inc	$ 3.0689 (-76.73%)	10.46M
FATFAT Brands Inc	$ 3.41 (-41.91%)	99.13k
SLXNSilexion Therapeutics Corporation	$ 2.01 (-35.99%)	7.37M
IRWDIronwood Pharmaceuticals Inc	$ 2.415 (-35.08%)	2.29M
MGOLMGO Global Inc	$ 0.117 (15.04%)	117.44M
NVDANVIDIA Corporation	$ 119.2401 (-3.61%)	98.68M
SPGCSacks Parente Golf Inc	$ 0.7876 (33.49%)	89.54M
KZIAKazia Therapeutics Ltd	$ 2.0999 (52.17%)	84.93M
AMODAlpha Modus Holdings Inc	$ 3.7768 (145.25%)	72.28M